FPF
CBAY

FNY Partners Fund’s Cymabay Therapeutics CBAY Stock Holding History

FNY Partners Fund’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,500
Closed -$23K – 1233
2017
Q1 		$23K Buy
+5,500
New +$15.8K ﹤0.01% 913

Other funds holding CBAY

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

FNY Partners Fund's CBAY Position: Q2 2017 in Review

FNY Partners Fund sold out of Cymabay Therapeutics (CBAY) in Q2 2017, closing a stake of 5,500 shares — an estimated $23K sold.

FNY Partners Fund first reported a position in CBAY in Q1 2017 and held it in 1 quarter. The position peaked at $23K in Q1 2017. 39 funds tracked by Wall St. Rank hold CBAY as of Q2 2017.

  • FNY Partners Fund reported no remaining Cymabay Therapeutics position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 5,500 Cymabay Therapeutics shares in Q2 2017, an estimated $23K.
  • FNY Partners Fund first reported a position in Cymabay Therapeutics in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Cymabay Therapeutics position peaked at $23K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.